Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > Net Debt / (EBITDA-CAPEX)

Bristol-Myers Squibb Company Net Debt / (EBITDA-CAPEX) Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly Net Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Bristol-Myers Squibb Company Net Debt / (EBITDA-CAPEX) for the quarter ending September 09, 2020 was $1m a -149.02% decrease of -2m year over year
  • Bristol-Myers Squibb Company Net Debt / (EBITDA-CAPEX) for the last 12 months ending September 09, 2020 was $1m a -163.44% decrease of -2m year over year
  • Bristol-Myers Squibb Company Annual Net Debt / (EBITDA-CAPEX) for 2019 was $4m a 113.45% increase of 4m from 2018
  • Bristol-Myers Squibb Company Annual Net Debt / (EBITDA-CAPEX) for 2018 was $-1m a 27.59% decrease of 0m from 2017
  • Bristol-Myers Squibb Company Annual Net Debt / (EBITDA-CAPEX) for 2017 was $0m a -38.57% increase of 0m from 2016
Other Ratios Metrics:
  • Bristol-Myers Squibb Company Total Debt / Capital for the quarter ending December 12, 2018 was $35m a -7.68% decrease of -3m year over year
  • Bristol-Myers Squibb Company Other Liabilities for the quarter ending September 09, 2018 was $4,603m a -12.23% decrease of -563m year over year
  • Bristol-Myers Squibb Company Total Debt / Equity for the quarter ending December 12, 2018 was $53m a -12.27% decrease of -7m year over year
View Chart On Koyfin

Quarterly BMY Net Debt / (EBITDA-CAPEX) Data

09/2020$1m
06/2020$1m
03/2020$2m
12/2019$3m
09/2019$-1m
06/2019$-1m
03/2019$0m
12/2018$-1m
09/2018$0m
06/2018$0m

Annual BMY Net Debt / (EBITDA-CAPEX) Data

2019$4m
2018$-1m
2017$0m
2016$-1m
2015$-1m
2014$-1m
2013$0m
2012$0m
2011$-1m
2010$-1m